Connecticut Innovations said it recently invested $750,000 in New Haven's Precipio Diagnostics, which has agreements with Yale University to evaluate patient samples and produce pathology reports.
The state's quasi-public venture capital arm led the $1.8 million Series B funding round, which also included Ironwood Capital, Enhanced Capital, Kuzari Capital and individual investors.
"We are highly encouraged by the strong traction of the company's services are receiving g in the marketplace and by the company's growth to date," Claire Leonardi, CI's CEO, said in a statement.
Precipio began generating revenue about 18 months ago and now has 14 employees, including several executives who are faculty at Yale's medical school.
Image credit: www.freedigitalphotos.net
|Today's Poll||Can UConn men's/women's basketball maintain elite status outside a Power Five conference?<